Related Experiment Video
Updated: May 23, 2026
07:40
Experimental Autoimmune Uveitis: An Intraocular Inflammatory Mouse Model
Published on: January 12, 2022
Interferon-α therapy in noninfectious uveitis
Christoph Deuter1, Nicole Stübiger, Manfred Zierhut
1Centre for Ophthalmology, University of Tübingen, Tübingen, Germany.
Developments in Ophthalmology
|April 21, 2012
Summary
Interferon-alpha (IFN-α) effectively treats Behçet's disease-associated uveitis, inducing remission in 94% of patients. This cytokine therapy offers sustained remission even after treatment cessation, highlighting its therapeutic potential for intraocular inflammation.
Area of Science:
- Immunology
- Ophthalmology
- Pharmacology
Background:
- Interferon (IFN)-α and IFN-β are cytokines with immunomodulatory effects.
- IFN-α has shown promise in treating Behçet's disease (BD) and other forms of uveitis.
Purpose of the Study:
- To review the mechanisms, pharmacology, and clinical efficacy of IFN-α in intraocular inflammation.
- To summarize the side effect profile of IFN-α treatment.
Main Methods:
- Review of existing case reports and clinical studies on IFN-α for uveitis.
- Analysis of treatment outcomes, remission rates, and side effects.
Main Results:
- IFN-α achieved complete or partial remission in approximately 94% of BD-associated uveitis patients within 2-4 weeks.
- IFN-α is the only drug reported to induce stable remission post-treatment discontinuation.
- Recommended dosage is 3-6 million IU/day; lower doses may increase recurrence.
Conclusions:
- IFN-α is a highly effective treatment for BD-associated uveitis, offering sustained remission.
- Common side effects include flu-like symptoms and mild leukopenia; others are rare.
- Further understanding of IFN-α mechanisms and clinical applications in ophthalmology is warranted.
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:27Open Angle Glaucoma: Treatment
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
01:28Angle Closure Glaucoma: Treatment
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...